# EDGAR Filing Document

**Accession Number:** 0001861657
**File Stem:** 0001641172-25-018155
**Filing Date:** 2025-7
**Character Count:** 2569
**Document Hash:** eb9a9e7e39c89be7f579fa1ed5f101a3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-018155.hdr.sgml**: 20250806

**ACCESSION NUMBER**: 0001641172-25-018155

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250708

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tharimmune, Inc.
- **CENTRAL INDEX KEY:** 0001861657
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 842642541
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1200 ROUTE 22 EAST
- **CITY:** BRIDGEWATER
- **STATE:** NJ
- **ZIP:** 08807
- **BUSINESS PHONE:** 302-743-2995

**MAIL ADDRESS:**
- **STREET 1:** 245 MAIN STREET
- **STREET 2:** SUITE 204
- **CITY:** CHESTER
- **STATE:** NJ
- **ZIP:** 07930

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Tharimmune, Inc
- **DATE OF NAME CHANGE:** 20230925

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Hillstream BioPharma Inc.
- **DATE OF NAME CHANGE:** 20210511

**Tharimmune, Inc.**

**34 Shrewsbury Avenue**

**Red Bank, NJ 07701**

July 8, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance<br> 100 F Street, N.E.

Washington, D.C. 20549

Attention: Daniel Crawford

---

| | |
|:---|:---|
| **Re:** | **Tharimmune, Inc.** |
|  | **Registration Statement on Form S-3** |
|  | **File No. 333-288518** |
|  | **Filed July 3, 2025** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), Tharimmune, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Daylight Time, on Wednesday, July 9, 2025, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Please notify Jeffrey Fessler of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the registration statement has been declared effective pursuant to this acceleration request.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **THARIMMUNE, INC.** | **THARIMMUNE, INC.** |
| By: | */s/ Sireesh Appajosyula* |
| Name: | Sireesh Appajosyula |
| Title: | Chief Executive Officer |

---

cc: Jeffrey Fessler, Sheppard Mullin Richter & Hampton LLP